本页面由Tiger Trade Technology Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

30.21
-0.6100-1.98%
盘后:30.210.00000.00%19:30 EDT
成交量:116.87万
成交额:3,538.35万
市值:17.97亿
市盈率:-4.31
高:30.99
开:30.60
低:30.10
收:30.82
52周最高:46.00
52周最低:22.24
股本:5,947.16万
流通股本:5,008.85万
量比:0.90
换手率:2.33%
股息:- -
股息率:- -
每股收益(TTM):-7.0075
每股收益(LYR):-7.1203
净资产收益率:-34.34%
总资产收益率:-22.24%
市净率:1.75
市盈率(LYR):-4.24

数据加载中...

2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/02

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities